½ÃÀ庸°í¼­
»óǰÄÚµå
1589201

¼¼°èÀÇ µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå : ÀÓÇöõÆ® À¯Çü, Ä¡·á¹ý, Àç·á, ºÎÀ§, ÃÖÁ¾ »ç¿ëÀÚ, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Craniomaxillofacial Devices Market by Implant Type, Treatment, Material, Location, End-Users, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀåÀº 2023³â¿¡ 21¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 23¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.15%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 41¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

µÎ°³°ñ ¾È¸é µð¹ÙÀ̽º´Â µÎ°³°ñ°ú ¾È¸é ¿µ¿ªÀÇ ¼ö¼ú Àç°Ç ¹× ¼ö¸®¸¦ À§ÇØ Æ¯º°È÷ ¼³°èµÈ ÀÇ·á±â±âÀÌ¸ç ¼±Ãµ¼º ÀÌ»ó ±³Á¤, ¿Ü»ó Ä¡·á, ¼±ÅÃÀû ¹Ì¿ë ¼ºÇü¼ú Áö¿ø µî ´Ù¾çÇÑ »ç¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±¸ÀÇ Çʿ伺Àº ¿Ü»ó ¹ß»ý·ü Áõ°¡¿Í ¾È¸é º¯ÇüÀÇ ±³Á¤¿¡ ´ëÇÑ Àνİú ´É·Â Áõ°¡¸¦ °í·ÁÇÏ¸é °¡Àå Áß¿äÇÕ´Ï´Ù. º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), Àü¹® Ŭ¸®´Ð µî¿¡¼­ Æø³Ð°Ô ä¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀº ¼ö¼ú °á°ú¿Í ȯÀÚÀÇ È¸º¹À» ³ôÀÌ´Â 3D ÇÁ¸°ÆÃ, ÀÓÇöõÆ® Àç·á ¹× ÄÄÇ»ÅÍ Áö¿ø ¼³°è ±â¼úÀÇ Áøº¸¿¡ Å©°Ô ¿µÇâÀ» ¹Þ°í ÃÖ÷´Ü Àåºñ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Àúħ½À ¼ö¼ú ¼ö¼úÀÇ Ã¤¿ë È®´ëµµ ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ÀÇ·áºñ Áõ´ë¿¡ ÀÇÇÑ ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ±Þ¼ºÀåµµ ½ÃÀå È®´ëÀÇ È£±âÀÔ´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ °úÁ¤, ÀåºñÀÇ °íºñ¿ë, °¨¿° ¹× ÀÓÇöõÆ® °ÅºÎ ¹ÝÀÀÀ» Æ÷ÇÔÇÑ ÀáÀçÀû À§Çè°ú °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ ¾î·Á¿öÁö°í ÀÖ½À´Ï´Ù. Àú¼Òµæ Áö¿ª¿¡¼­´Â ÀÎÇÁ¶ó°¡ Á¦ÇÑµÇ¾î ¼ºÀå Àü¸ÁÀÌ ´õ¿í ³·¾ÆÁö°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀ» À§Çؼ­´Â »ýü Èí¼ö¼º ÀÓÇöõÆ® °³¹ß, »ýü ÀûÇÕ¼ºÀ» ³ôÀÌ´Â Àç·á °­È­, Á¤È®ÇÑ ¼ö¼ú °èȹÀ» À§ÇÑ AI Ȱ¿ë¿¡ ÁßÁ¡À» µÎ¾î¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ ¸ÂÃãÇü ÀÇ·á ¹× È¯ÀÚ Àü¿ë ÀåÄ¡ Á¶»ç´Â ºñÁî´Ï½º ¼ºÀåÀÇ Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ½ÃÀå »óȲÀº ºü¸£°Ô ÁøÈ­Çϰí ÀÖÀ¸¸ç ±â¼ú°ú ÀÇÇÐÀÇ À¶ÇÕÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å±â¾÷°úÀÇ ¿¬±¸ Á¦ÈÞÀÇ Áö¼Ó, Áö¿ªÁ¤¼¼º° ÇÁ·¹Áð½ºÀÇ È®´ë, µð¹ÙÀ̽ºÀÇ ½ÂÀΰú µµÀÔÀ» ½Å¼ÓÈ­Çϱâ À§ÇÑ ±ÔÁ¦ Àü·«ÀÇ ¼¼·Ã µîÀÌ Àü·«Àû Á¦¾ÈÀÇ Áß½ÉÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¾ß¿¡ ÁÖ·ÂÇÔÀ¸·Î½á ±â¾÷Àº ÇöÀçÀÇ °úÁ¦¸¦ ÇØ°áÇÏ°í ½ÃÀåÀÇ ¿ªµ¿ÀûÀÎ ¼ºÁúÀ» Ȱ¿ëÇÏ¿© ¼ö¼ú °á°ú¿Í ȯÀÚ ¸¸Á·µµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ¾î °æÀïÀÌ °ÝÈ­µÇ´Â ºÐ¾ß¿¡¼­ Áö¼ÓÀûÀÎ ¼ºÀå À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 21¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 23¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 41¾ï 8,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 10.15%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â µÎ°³ÅÎ ¾È¸é ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

µÎ°³ÅÎ ¾È¸é ÀåÄ¡ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ³ôÀº ±âÈ£¼º
    • ½ºÆ÷Ã÷ ¿Ü»óÀ̳ª ±³Åë »ç°í¿¡ ÀÇÇÑ ¾È¸é, µÎºÎ ¿Ü»ó Áõ°¡
    • ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ ±Ù´ëÈ­ÀÇ ÁøÀü°ú ¿¬±¸°³¹ß Ȱµ¿ÀÇ ¼ºÀå
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀåºñÀÇ °í°¡°Ý
  • ½ÃÀå ±âȸ
    • ±â¼ú Çõ½Å°ú ±â¼úÀûÀ¸·Î Áøº¸ÇÑ Á¦Ç°
    • ÀÇ·á ½Ã¼³°ú Á¦Á¶¾÷ü¿¡ ÀÇÇÑ ÅõÀÚÀÇ ±ÞÁõ
  • ½ÃÀåÀÇ °úÁ¦
    • ½ÅÈï °æÁ¦ ±¹°¡ÀÇ °Ç°­ °ü¸® ÀÎÇÁ¶ó ºñÀ²ÀÌ ³·À½

Porter's Five Forces : µÎ°³°ñ ¾È¸é µð¹ÙÀ̽º ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇϱâ À§ÇÑ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : µÎ°³°ñ ¾È¸é µð¹ÙÀ̽º ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº µÎ°³°ñ ¾È¸é µð¹ÙÀ̽º ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. È¿°ú¸¦ Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® µÎ°³°ñ ¾È¸é µð¹ÙÀ̽º ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

µÎ°³°ñ ¾È¸é µð¹ÙÀ̽º ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Æ÷Áö¼Å´× ºÎµå·´°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¸íÈ®È÷ÇÏ°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º µÎ°³ÅÎ ¾È¸é ÀåÄ¡ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â µÎ°³°ñ ¾È¸é µð¹ÙÀ̽º ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ µÎ°³ÅÎ ¾È¸é ÀåÄ¡ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ³ôÀº ÃëÇâ
      • ½ºÆ÷Ã÷ °ü·Ã ºÎ»óÀ̳ª ±³Åë »ç°í·Î ÀÎÇÑ ¾ó±¼°ú ¸Ó¸® ºÎ»ó Áõ°¡
      • ÇコÄÉ¾î ºÐ¾ßÀÇ ±Ù´ëÈ­ÀÇ ÁøÀü°ú ¿¬±¸ °³¹ß Ȱµ¿ÀÇ ¼ºÀå
    • ¾ïÁ¦¿äÀÎ
      • µð¹ÙÀ̽ºÀÇ ºñ¿ëÀÌ ³ô´Ù
    • ±âȸ
      • Çõ½Å°ú ±â¼úÀûÀ¸·Î °í±Þ Á¦Ç°
      • ÀÇ·á ½Ã¼³°ú Á¦Á¶¾÷ü¿¡ ÀÇÇÑ ÅõÀÚÀÇ ±ÞÁõ
    • °úÁ¦
      • ½ÅÈï °æÁ¦ ±¹°¡ÀÇ °Ç°­ °ü¸® ÀÎÇÁ¶ó Á¤ºñÀ²ÀÌ ³·´Ù
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå : ÀÓÇöõÆ®À¯Çüº°

  • ¸ÂÃãÇü ¶Ç´Â ȯÀÚ °íÀ¯ÀÇ ÀÓÇöõÆ®
  • Ç¥ÁØ ÀÓÇöõÆ®

Á¦7Àå µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå Ä¡·áº°

  • »À ÀÌ½Ä ´ëüǰ
  • CMF »ê¸¸
  • CMF Ç÷¹ÀÌÆ®¿Í ³ª»ç °íÁ¤
  • µÎ°³ÇÇÆÇ °íÁ¤
  • ÅΰüÀý ġȯ¼ú
  • ÈäºÎ °íÁ¤

Á¦8Àå µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå : ¼ÒÀ纰

  • »ýü Èí¼ö¼º Àç·á
  • µµ¿¹
  • ±Ý¼Ó ¹× ÇÕ±Ý

Á¦9Àå µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå Àå¼Òº°

  • ¿ÜºÎ °íÁ¤±â±¸
  • ³»ºÎ °íÁ¤±â±¸

Á¦10Àå µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ¹Ì¿ë ¿Ü°ú ÀÇ»ç
  • º´¿ø
  • ¿Ü°úÀÇ

Á¦11Àå µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå : ¿ëµµº°

  • ³ú½Å°æ¿Ü°ú, À̺ñÀÎÈİú
  • ±³Á¤Ä¡°ú ¹× Ä¡°ú ¼ö¼ú
  • ¼ºÇü¿Ü°ú

Á¦12Àå ¾Æ¸Þ¸®Ä«ÀÇ µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦13Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦14Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µÎ°³ÅÎ ¾È¸é µð¹ÙÀ̽º ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3D Systems, Inc.
  • Acumed LLC
  • Antibe Therapeutics Inc.
  • Calavera Surgical Design
  • Integra LifeSciences Pvt Ltd.
  • Invisian Medical, LLC
  • Jabil Inc.
  • Johnson & Johnson Services, Inc.
  • KLS Martin Group
  • Matrix Surgical USA
  • Medartis AG
  • Medtronic PLC
  • Renishaw PLC
  • Stryker Corporation
  • Zimmer Biomet Holding Inc.
BJH 24.11.21

The Craniomaxillofacial Devices Market was valued at USD 2.12 billion in 2023, expected to reach USD 2.34 billion in 2024, and is projected to grow at a CAGR of 10.15%, to USD 4.18 billion by 2030.

Craniomaxillofacial devices are medical equipment specifically designed for the surgical reconstruction and repair of the skull and facial regions, encompassing a range of applications that include correcting congenital anomalies, addressing trauma, and supporting elective cosmetic procedures. The necessity of these devices is paramount, given the increasing incidence of trauma cases, as well as the rising awareness and ability for correction of facial deformities. They are extensively employed across hospitals, ambulatory surgical centers, and specialty clinics. Market growth is heavily influenced by advancements in 3D printing, implant materials, and computer-assisted design technologies that enhance surgical outcomes and patient recovery, propelling the demand for cutting-edge devices. Growing adoption of minimally invasive surgical techniques also contributes significantly to market expansion. Opportunities abound in the increased investment in healthcare infrastructure and the burgeoning regional markets in Asia-Pacific due to escalating healthcare expenditure. However, market growth is challenged by factors such as stringent regulatory processes, high cost of devices, and potential risks including infection or implant rejection. Limitations in infrastructure in low-income regions further curtail growth prospects. For innovation, the focus should be on developing bioresorbable implants, enhanced materials for better biocompatibility, and leveraging AI for accurate surgical planning. Further, research into personalized medicine and patient-specific devices holds substantial promise for business growth. The craniomaxillofacial devices market epitomizes a rapidly evolving landscape, integrating technology with medical science, suggesting strategic recommendations center around continued research partnerships with tech innovates, expansion of geographical presence, and refining regulatory strategies to expedite device approval and introduction. By focusing on these areas, companies can address current challenges and capitalize on the market's dynamic nature to enhance surgical outcomes and patient satisfaction, thus ensuring sustainable growth in an increasingly competitive field.

KEY MARKET STATISTICS
Base Year [2023] USD 2.12 billion
Estimated Year [2024] USD 2.34 billion
Forecast Year [2030] USD 4.18 billion
CAGR (%) 10.15%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Craniomaxillofacial Devices Market

The Craniomaxillofacial Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High preference for minimally invasive surgeries
    • Rising cases of facial and head injuries caused due to sports-related injuries and road accidents
    • Increasing modernization in the healthcare sector and growth in research and development activities
  • Market Restraints
    • High cost of the devices
  • Market Opportunities
    • Innovations and technologically advanced products
    • Surge in investments by the health care facilities and the manufacturers
  • Market Challenges
    • Low healthcare infrastructure rates in the developing economies

Porter's Five Forces: A Strategic Tool for Navigating the Craniomaxillofacial Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Craniomaxillofacial Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Craniomaxillofacial Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Craniomaxillofacial Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Craniomaxillofacial Devices Market

A detailed market share analysis in the Craniomaxillofacial Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Craniomaxillofacial Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Craniomaxillofacial Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Craniomaxillofacial Devices Market

A strategic analysis of the Craniomaxillofacial Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Craniomaxillofacial Devices Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., Acumed LLC, Antibe Therapeutics Inc., Calavera Surgical Design, Integra LifeSciences Pvt Ltd., Invisian Medical, LLC, Jabil Inc., Johnson & Johnson Services, Inc., KLS Martin Group, Matrix Surgical USA, Medartis AG, Medtronic PLC, Renishaw PLC, Stryker Corporation, and Zimmer Biomet Holding Inc..

Market Segmentation & Coverage

This research report categorizes the Craniomaxillofacial Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Implant Type, market is studied across Customized or Patient-Specific Implants and Standard Implants.
  • Based on Treatment, market is studied across Bone Graft Substitute, CMF Distraction, CMF Plate & Screw Fixation, Cranial Flap Fixation, Temporomandibular Joint Replacement, and Thoracic Fixation.
  • Based on Material, market is studied across Bioabsorbable Material, Ceramics, and Metal & Alloys.
  • Based on Location, market is studied across External Fixators and Internal Fixators.
  • Based on End-Users, market is studied across Ambulatory Surgery Centres, Cosmetic Surgeons, Hospitals, and Surgeons.
  • Based on Application, market is studied across Neurosurgery & ENT, Orthognathic & Dental Surgery, and Plastic surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High preference for minimally invasive surgeries
      • 5.1.1.2. Rising cases of facial and head injuries caused due to sports-related injuries and road accidents
      • 5.1.1.3. Increasing modernization in the healthcare sector and growth in research and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations and technologically advanced products
      • 5.1.3.2. Surge in investments by the health care facilities and the manufacturers
    • 5.1.4. Challenges
      • 5.1.4.1. Low healthcare infrastructure rates in the developing economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Craniomaxillofacial Devices Market, by Implant Type

  • 6.1. Introduction
  • 6.2. Customized or Patient-Specific Implants
  • 6.3. Standard Implants

7. Craniomaxillofacial Devices Market, by Treatment

  • 7.1. Introduction
  • 7.2. Bone Graft Substitute
  • 7.3. CMF Distraction
  • 7.4. CMF Plate & Screw Fixation
  • 7.5. Cranial Flap Fixation
  • 7.6. Temporomandibular Joint Replacement
  • 7.7. Thoracic Fixation

8. Craniomaxillofacial Devices Market, by Material

  • 8.1. Introduction
  • 8.2. Bioabsorbable Material
  • 8.3. Ceramics
  • 8.4. Metal & Alloys

9. Craniomaxillofacial Devices Market, by Location

  • 9.1. Introduction
  • 9.2. External Fixators
  • 9.3. Internal Fixators

10. Craniomaxillofacial Devices Market, by End-Users

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centres
  • 10.3. Cosmetic Surgeons
  • 10.4. Hospitals
  • 10.5. Surgeons

11. Craniomaxillofacial Devices Market, by Application

  • 11.1. Introduction
  • 11.2. Neurosurgery & ENT
  • 11.3. Orthognathic & Dental Surgery
  • 11.4. Plastic surgery

12. Americas Craniomaxillofacial Devices Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Craniomaxillofacial Devices Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Craniomaxillofacial Devices Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D Systems, Inc.
  • 2. Acumed LLC
  • 3. Antibe Therapeutics Inc.
  • 4. Calavera Surgical Design
  • 5. Integra LifeSciences Pvt Ltd.
  • 6. Invisian Medical, LLC
  • 7. Jabil Inc.
  • 8. Johnson & Johnson Services, Inc.
  • 9. KLS Martin Group
  • 10. Matrix Surgical USA
  • 11. Medartis AG
  • 12. Medtronic PLC
  • 13. Renishaw PLC
  • 14. Stryker Corporation
  • 15. Zimmer Biomet Holding Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦